Daphne Zohar

Daphne Zohar is a prominent figure in the biotechnology sector, currently serving as the Founder and CEO of Seaport Therapeutics, a company focused on developing innovative therapies for mental health and neurodegenerative diseases. She is also the Founder and CEO of PureTech Health, a biotherapeutics company she established in 2005, which has been instrumental in creating numerous novel therapeutics and has co-founded several entities, including Karuna Therapeutics, which was acquired by Bristol Myers Squibb.12

In addition to her executive roles, Zohar holds a position as a Board Member of the Biotechnology Innovation Organization since February 2023, where she contributes to shaping policies and strategies within the biotech community.1 She is also a co-founder and host of Biotech Hangout, a platform that discusses various topics in biotechnology, including investment dynamics and drug development challenges.2

Zohar's extensive experience and insights into the biotech industry are often shared through various media appearances and discussions, where she addresses complexities in drug development and the future of mental health treatments.2 Her leadership has significantly impacted the biotech landscape, particularly in advancing therapeutic solutions for challenging health issues.